# IMNN (Imunon, Inc.) - SEC EDGAR Financial Statements

> Imunon, Inc. reported $12.01M in total assets and a net loss of $15.04M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/IMNN
- Markdown: https://convexityos.com/fundamentals/IMNN.md
- SEC CIK: 0000749647
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:09 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000749647&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$14.81M | Operating profit |
| Net Income | FY 2025 | -$15.04M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$2.53 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$14.18M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $4.04M | Total debt: $708K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | $500K | $500K | $500K | $500K | $500K | $500K | -- |
| Research & Development | $7.78M | $11.64M | $11.29M | $11.73M | $10.62M | $11.34M | $13.07M | $11.87M | $13.08M | $14.62M |
| Total Operating Expenses | $14.65M | $19.13M | $21.03M | $25.42M | $21.51M | $18.99M | $21.07M | $21.57M | $18.97M | $21.15M |
| **Operating Income** | -$14.65M | -$19.13M | -$21.03M | -$24.92M | -$21.01M | -$18.49M | -$20.57M | -$21.07M | -$18.47M | -$20.65M |
| **EBITDA** | -$14.36M | -$18.89M | -$20.78M | -$24.19M | -$20.30M | -$17.74M | -$19.84M | -$20.71M | -$17.92M | -$19.63M |
| Interest Income | -- | $450K | $726K | $503K | $18K | $67K | $443K | $364K | $26K | $31K |
| Interest Expense | -- | -- | $197K | $5.03M | $570K | $1.29M | $1.39M | $712K | $92K | $723K |
| Income Before Tax | $14.50M | $18.60M | -$20.80M | -$37.47M | -$22.15M | -$23.33M | -$18.67M | -$22.30M | -$20.40M | -- |
| Income Tax Expense | -- | -- | -$1.28M | -$1.57M | -$1.38M | -$1.85M | -$1.82M | -$10.42M | -- | -- |
| **Net Income** | -$14.50M | -$18.62M | -$19.51M | -$35.90M | -$20.77M | -$21.48M | -$16.85M | -$11.88M | -$20.40M | -$22.05M |
| Basic EPS | -$6.83 | -$16.94 | -$3,698.49 | -$8,612.69 | -$6,557.97 | -$17,259.62 | -$1,318.44 | -$1,164.34 | -$4,657.36 | -$20,358.82 |
| **Diluted EPS** | -$6.83 | -$16.94 | -$3,698.49 | -$8,612.69 | -$6,557.97 | -$17,259.62 | -$1,318.44 | -$1,164.34 | -$4,657.36 | -$20,358.82 |
| Basic Shares Outstanding | 2.1M | 1.1M | 5.3K | 4.2K | 3.2K | 1.2K | 12.8K | 10.3K | 4.5K | 1.1K |
| Diluted Shares Outstanding | 2.1M | 1.1M | 5.3K | 4.2K | 3.2K | 1.2K | 12.8K | 10.3K | 4.5K | 1.1K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $1.79M | $1.46M | $2.34M | $2.49M | $1.90M | $1.23M | $2.17M | $2.23M |
| Total Operating Expenses | $3.45M | $2.79M | $4.31M | $4.26M | $3.48M | $2.77M | $4.15M | $4.15M |
| **Operating Income** | -$3.45M | -$2.79M | -$4.31M | -$4.26M | -$3.48M | -$2.77M | -$4.15M | -$4.15M |
| **EBITDA** | -$3.38M | -$2.72M | -$4.24M | -$4.19M | -$3.40M | -$2.69M | -$4.08M | -$4.11M |
| Interest Income | -- | -- | -- | -- | -- | -- | -- | $89K |
| Interest Expense | $264K | $77K | -- | -- | -- | -- | -- | -- |
| **Net Income** | -$3.75M | -$2.81M | -$4.25M | -$4.22M | -$3.43M | -$2.74M | -$4.10M | -$4.06M |
| Basic EPS | -$0.64 | -$0.54 | -$0.84 | -- | -$1.16 | -$2.15 | -$3.15 | -- |
| **Diluted EPS** | -$0.64 | -$0.54 | -$0.84 | -- | -$1.16 | -$2.15 | -$3.15 | -- |
| Basic Shares Outstanding | 5.9M | 5.2M | 5.0M | -- | 2.9M | 1.3M | 1.3M | -- |
| Diluted Shares Outstanding | 5.9M | 5.2M | 5.0M | -- | 2.9M | 1.3M | 1.3M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $8.78M | $5.87M | $5.84M | $11.49M | $19.59M | $17.16M | $6.88M | $13.35M | $11.44M | $2.62M |
| Short-Term Investments | -- | -- | $9.80M | $21.23M | $29.81M | -- | $7.94M | $14.23M | $12.73M | $1.68M |
| **Cash & Short-Term Investments** | $8.80M | $5.90M | $15.70M | $32.80M | $56.90M | $17.16M | $14.82M | $27.58M | $24.20M | $4.30M |
| Accounts Receivable, Net | $0 | $0 | $0 | $0 | -- | $0 | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- | -- | -- | -- | -- | $115K |
| **Total Current Assets** | $10.72M | $8.01M | $18.24M | $36.78M | $51.95M | $18.82M | $16.24M | $28.13M | $24.31M | $4.51M |
| Property, Plant & Equipment, Net | $530K | $541K | $752K | $548K | $477K | $295K | $405K | $185K | $176K | $463K |
| Goodwill | -- | -- | -- | -- | -- | $1.98M | $1.98M | $1.98M | $1.98M | $1.98M |
| Intangible Assets | -- | -- | -- | -- | -- | $114K | $341K | $568K | $796K | $1.02M |
| Other Non-Current Assets | $1.03M | $1.17M | $2.93M | $6.65M | $21.62M | $18.41M | $21.64M | -- | $8.8K | $8.8K |
| **Total Non-Current Assets** | $1.56M | $1.71M | $3.68M | $7.20M | $22.10M | $18.70M | $21.64M | $18.54M | $23.03M | $25.87M |
| **Total Assets** | $12.29M | $9.72M | $21.92M | $43.98M | $74.05M | $37.53M | $38.28M | $46.86M | $47.51M | $30.85M |
| Accounts Payable | $1.39M | $1.30M | $3.52M | $3.59M | $2.55M | $2.24M | $2.86M | $3.02M | $3.42M | $2.88M |
| Deferred Revenue (Current) | -- | -- | -- | -- | $500K | $500K | $500K | $500K | $500K | $500K |
| **Total Current Liabilities** | $4.62M | $4.79M | $7.39M | $10.04M | $6.77M | $6.75M | $7.89M | $6.11M | $6.20M | $8.42M |
| Long-Term Debt | -- | -- | -- | $5.96M | -- | $5.05M | $9.80M | $9.42M | -- | -- |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | $500K | $1.00M | $1.50M | $2.00M | $2.50M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $63K | $72K | $12K |
| **Total Non-Current Liabilities** | $602K | $687K | $1.14M | $4.61M | $11.48M | $12.16M | $15.82M | $19.89M | $14.61M | $15.70M |
| **Total Liabilities** | $5.23M | $5.47M | $8.53M | $14.65M | $18.25M | $18.92M | $23.72M | $25.99M | $20.81M | $24.12M |
| **Total Debt (incl. Leases)** | $1.01M | $1.14M | $1.62M | $6.20M | $780K | $6.19M | $11.34M | $10.72M | -- | -- |
| Common Stock | $34K | $9.7K | $94K | $74K | $58K | $27K | $233K | $188K | $173K | $22K |
| Retained Earnings | -$421.3M | -$406.8M | -$388.2M | -$368.7M | -$332.8M | -$312.0M | -$290.5M | -$273.7M | -$261.8M | -$241.4M |
| Accumulated Other Comp. Income | $0 | $0 | $61K | $26K | -$8.0K | -- | $43K | $30K | -$10K | -- |
| **Total Stockholders' Equity** | $7.06M | $4.24M | $13.39M | $29.33M | $55.80M | $18.61M | $14.56M | $20.86M | $26.70M | $6.73M |
| Total Equity | $7.06M | $4.24M | $13.39M | $29.33M | $55.80M | $18.61M | $14.56M | $20.86M | $26.70M | $6.73M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $4.04M | $6.86M | $4.79M | $8.78M | $5.25M | $4.73M | $2.87M | $5.87M |
| **Cash & Short-Term Investments** | $4.00M | $6.90M | $4.80M | $8.80M | $5.30M | $4.70M | $2.90M | $5.90M |
| Accounts Receivable, Net | -- | -- | -- | $0 | -- | -- | -- | $0 |
| **Total Current Assets** | $5.84M | $8.69M | $6.62M | $10.72M | $7.26M | $6.89M | $5.09M | $8.01M |
| Property, Plant & Equipment, Net | $394K | $459K | $460K | $530K | $601K | $677K | $734K | $541K |
| Other Non-Current Assets | $5.78M | $5.84M | $938K | $1.03M | $1.13M | $1.22M | $1.04M | $1.17M |
| **Total Non-Current Assets** | $6.17M | $6.30M | $1.40M | $1.56M | $1.73M | $1.90M | $1.77M | $1.71M |
| **Total Assets** | $12.01M | $14.99M | $8.02M | $12.29M | $8.99M | $8.79M | $6.86M | $9.72M |
| Accounts Payable | $1.28M | $1.62M | $965K | $1.39M | $1.13M | $1.74M | $1.86M | $1.30M |
| **Total Current Liabilities** | $4.24M | $4.78M | $4.17M | $4.62M | $4.20M | $5.32M | $5.80M | $4.79M |
| **Total Non-Current Liabilities** | $5.15M | $6.02M | $493K | $602K | $708K | $811K | $613K | $687K |
| **Total Liabilities** | $9.39M | $10.80M | $4.66M | $5.23M | $4.91M | $6.13M | $6.41M | $5.47M |
| **Total Debt (incl. Leases)** | $708K | $811K | $912K | $1.01M | $1.10M | $1.19M | $1.01M | $1.14M |
| Common Stock | $62K | $47K | $39K | $34K | $29K | $17K | $146K | $9.7K |
| Retained Earnings | -$432.1M | -$428.4M | -$425.5M | -$421.3M | -$417.1M | -$413.6M | -$410.9M | -$406.8M |
| Accumulated Other Comp. Income | -- | -- | -- | $0 | -- | -- | -- | $0 |
| **Total Stockholders' Equity** | $2.62M | $4.19M | $3.36M | $7.06M | $4.08M | $2.66M | $452K | $4.24M |
| Total Equity | $2.62M | $4.19M | $3.36M | $7.06M | $4.08M | $2.66M | $452K | $4.24M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$14.50M | -$18.62M | -$19.51M | -$35.90M | -$20.77M | -$21.48M | -$16.85M | -$11.88M | -$20.40M | -$22.05M |
| Depreciation & Amortization | $292K | $240K | $248K | $732K | $703K | $742K | $722K | $357K | $553K | $1.02M |
| Stock-Based Compensation | $127K | $477K | $759K | $2.67M | $3.76M | $1.85M | $2.29M | $4.60M | $1.11M | $1.51M |
| Change in Payables | -- | -- | -$1.99M | $2.11M | $302K | -$618K | -$158K | -$396K | $538K | $49K |
| **Operating Cash Flow** | -$13.90M | -$18.85M | -$19.02M | -$23.10M | -$16.22M | -$15.62M | -$20.26M | -$7.04M | -$16.64M | -$18.38M |
| Capital Expenditure | -$281K | -$30K | -$452K | -$268K | -$312K | -$19K | -$349K | -$138K | -$39K | -$63K |
| **Free Cash Flow** | -$14.18M | -$18.88M | -$19.47M | -$23.36M | -$16.54M | -$15.64M | -$20.61M | -$7.18M | -$16.68M | -$18.44M |
| Purchases of Investments | -- | -$57K | -$13.54M | -$48.23M | -$53.81M | -$9.96M | -- | -- | -- | -- |
| **Investing Cash Flow** | -$281K | $9.83M | $11.01M | $8.28M | -$30.12M | $7.92M | $5.94M | -$1.63M | -$10.99M | $9.06M |
| Common Stock Issued | $13.63M | $9.06M | $2.78M | $6.72M | $52.69M | $22.81M | $7.84M | $859K | -- | -- |
| **Financing Cash Flow** | $17.09M | $9.06M | -$3.64M | $6.72M | $54.77M | $17.98M | $7.84M | $10.58M | $36.45M | $2.68M |
| **Net Change in Cash** | $2.91M | $34K | -$11.65M | -$8.09M | $8.42M | $10.29M | -$6.48M | $1.91M | $8.82M | -$6.64M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$3.75M | -$2.81M | -$4.25M | -$4.22M | -$3.43M | -$2.74M | -$4.10M | -$4.06M |
| Depreciation & Amortization | $67K | $70K | $70K | $75K | $75K | $75K | $67K | $37K |
| Stock-Based Compensation | $90K | $93K | $549K | $11K | -$211K | $123K | $205K | $113K |
| **Operating Cash Flow** | -$3.20M | -$3.03M | -$3.99M | -$3.66M | -$4.44M | -$2.95M | -$2.85M | -$4.42M |
| Capital Expenditure | -- | -- | -- | -$3.6K | $0 | -$17K | -$260K | -$15K |
| **Free Cash Flow** | -- | -- | -- | -$3.66M | -$4.44M | -$2.97M | -$3.11M | -$4.44M |
| Purchases of Investments | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Investing Cash Flow** | -- | -- | -- | -$3.6K | $0 | -$17K | -$260K | -$15K |
| Common Stock Issued | -- | -- | -- | $7.19M | $3.47M | $2.86M | $106K | -- |
| **Financing Cash Flow** | $419K | $10.16M | -$1.8K | $7.19M | $4.96M | $4.83M | $106K | -- |
| **Net Change in Cash** | -$2.79M | $7.07M | -$3.99M | $3.53M | $522K | $1.86M | -$3.00M | -$4.44M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -4984.3% | -4201.4% | -3697.3% | -4113.1% | -4213.0% | -3693.7% | -- |
| **Net Profit Margin** | -- | -- | -- | -7179.6% | -4153.9% | -4296.7% | -3370.3% | -2376.7% | -4080.4% | -- |
| Return on Equity (ROE) | -205.3% | -438.7% | -145.8% | -122.4% | -37.2% | -115.4% | -115.7% | -57.0% | -76.4% | -327.9% |
| Return on Assets (ROA) | -118.0% | -191.6% | -89.0% | -81.6% | -28.0% | -57.2% | -44.0% | -25.4% | -42.9% | -71.5% |
| Current Ratio | 2.32x | 1.67x | 2.47x | 3.66x | 7.67x | 2.79x | 2.06x | 4.61x | 3.92x | 0.54x |
| Quick Ratio | 1.90x | 1.23x | 2.12x | 3.27x | 8.41x | 2.54x | 1.88x | 4.52x | 3.90x | 0.51x |
| Debt to Equity | 0.14x | 0.27x | 0.12x | 0.21x | 0.01x | 0.33x | 0.78x | 0.51x | -- | -- |
| **Revenue Growth (YoY)** | -- | -- | -- | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -- | -- |
| 5Y Revenue / Share Growth | -- | -- | -- | +6.8% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -573.4% | -351.3% | -435.8% | -205.3% | -351.1% | -592.0% | -3936.3% | -438.7% |
| Return on Assets (ROA) | -125.2% | -98.2% | -182.6% | -118.0% | -159.4% | -179.2% | -259.3% | -191.6% |
| Current Ratio | 1.38x | 1.82x | 1.59x | 2.32x | 1.73x | 1.30x | 0.88x | 1.67x |
| Quick Ratio | 0.94x | 1.44x | 1.15x | 1.90x | 1.26x | 0.88x | 0.50x | 1.23x |
| Debt to Equity | 0.27x | 0.19x | 0.27x | 0.14x | 0.27x | 0.45x | 2.23x | 0.27x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
